With the targets of the Vision 2026 plan interrupted by the pandemic and changes in China consumer appetite, leading to weak 2024 earnings, Kose has revamped its focus. The key components of its ...

Global Inc. (SPIR) reported strong revenue growth for the fourth quarter of 2024, but its stock experienced significant volatility. Despite a 13% increase in quarterly revenue, the stock price fell ...

Influential media outlets have been circulating research from a shadowy group without disclosing its links to the pharmaceutical industry.